(14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one

C31H39N7O5S — CID 139399987

IUPAC(14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one
SMILESCC1(C)C[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCC(O)C5CCC56CC6)n4)nc3N1C2
InChIInChI=1S/C31H39N7O5S/c1-30(2)17-20-5-4-15-32-24-6-3-7-27(33-24)44(41,42)36-29(40)21-8-9-25(34-28(21)37(30)18-20)38-16-11-26(35-38)43-19-23(39)22-10-12-31(22)13-14-31/h3,6-9,11,16,20,22-23,39H,4-5,10,12-15,17-19H2,1-2H3,(H,32,33)(H,36,40)/t20-,22?,23?/m0/s1
InChIKeyOKBQRNNSIHDMIZ-RBKXMNCYSA-N
MW621.76 g/mol
LogP3.52
Rot. Bonds5

About (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one

(14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one (PubChem CID 139399987) has the molecular formula C31H39N7O5S and a molecular weight of 621.76 g/mol. Its IUPAC name is (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one.

Molecular Properties

Compound Name(14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one
PubChem CID139399987
Molecular FormulaC31H39N7O5S
Molecular Weight621.76 g/mol
Exact Mass621.27
IUPAC Name(14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one
SMILESCC1(C)C[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCC(O)C5CCC56CC6)n4)nc3N1C2
InChIInChI=1S/C31H39N7O5S/c1-30(2)17-20-5-4-15-32-24-6-3-7-27(33-24)44(41,42)36-29(40)21-8-9-25(34-28(21)37(30)18-20)38-16-11-26(35-38)43-19-23(39)22-10-12-31(22)13-14-31/h3,6-9,11,16,20,22-23,39H,4-5,10,12-15,17-19H2,1-2H3,(H,32,33)(H,36,40)/t20-,22?,23?/m0/s1
InChIKeyOKBQRNNSIHDMIZ-RBKXMNCYSA-N
XLogP3.52
TPSA151.57 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds5
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500621.76
LogP ≤ 53.52
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one?
The IUPAC name of (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one (CID 139399987) is (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one.
What is the SMILES notation for (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one?
The canonical SMILES for (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one is CC1(C)C[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCC(O)C5CCC56CC6)n4)nc3N1C2.
What is the InChIKey of (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one?
The InChIKey is OKBQRNNSIHDMIZ-RBKXMNCYSA-N. The full InChI is InChI=1S/C31H39N7O5S/c1-30(2)17-20-5-4-15-32-24-6-3-7-27(33-24)44(41,42)36-29(40)21-8-9-25(34-28(21)37(30)18-20)38-16-11-26(35-38)43-19-23(39)22-10-12-31(22)13-14-31/h3,6-9,11,16,20,22-23,39H,4-5,10,12-15,17-19H2,1-2H3,(H,32,33)(H,36,40)/t20-,22?,23?/m0/s1.
What are the key properties of (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one?
(14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one has a molecular weight of 621.76 g/mol, XLogP of 3.52, 5 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (14S)-8-[3-(2-hydroxy-2-spiro[2.3]hexan-6-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one is sourced from PubChem (CID 139399987), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).